pantoprazole

It is used to treat symptoms of stomach and intestinal diseases related to excessive acid secretion, such as heartburn, pain when swallowing, or acid reflux. It also helps in the long-term treatment of esophagitis and in preventing gastric and duodenal ulcers in individuals who continuously take anti-inflammatory drugs (NSAIDs).

Form: tablets, enteric-coated

ATC: A02BC02

Manufacturer: Adamed Pharma S.A.

It is used in the treatment of stomach and intestinal diseases related to excessive hydrochloric acid secretion. In adults and adolescents over 12 years of age, it helps in the treatment of reflux esophagitis. In adults, it is also used in the treatment of gastric and duodenal ulcers and in the eradication of Helicobacter pylori bacteria (in combination with antibiotics), as well as in Zollinger-Ellison syndrome.

Form: tablets, enteric-coated

ATC: A02BC02

Manufacturer: Adamed Pharma S.A.

The medicine is used for the short-term treatment of symptoms of gastroesophageal reflux disease in adults, such as heartburn or acid regurgitation.

Form: tablets, enteric-coated

ATC: A02BC02

Manufacturer: Adamed Pharma S.A. S.C. Terapia S.A.

The medicine is used in adults and adolescents over 12 years of age for the treatment of reflux esophagitis. In adults, it is also used for the treatment of gastric and duodenal ulcer disease, Helicobacter pylori infection (in combination with antibiotics), and Zollinger-Ellison syndrome and other conditions related to excessive hydrochloric acid secretion.

Form: tablets, enteric-coated

ATC: A02BC02

Manufacturer: Pharmaceutical Enterprise LEK-AM Ltd.

The medicine is used in adults and adolescents over 12 years of age to treat symptoms of gastroesophageal reflux disease (such as heartburn, pain on swallowing, or acid regurgitation) and for the long-term treatment and prevention of recurrence of esophagitis. In adults, it is also used to prevent gastric and duodenal ulcers in individuals who must take continuous anti-inflammatory drugs (NSAIDs).

Form: tablets, enteric-coated

ATC: A02BC02

Manufacturer: Pharmaceutical Enterprise LEK-AM Ltd.

The medicine is used in adults and adolescents over 12 years of age for the treatment of reflux esophagitis. In adults, it is also used for the treatment of gastric and duodenal ulcer disease, Helicobacter pylori infection (in combination with antibiotics), Zollinger-Ellison syndrome, and other conditions associated with excessive hydrochloric acid secretion.

Form: tablets, enteric-coated

ATC: A02BC02

Manufacturer: Delpharm Novara S.r.l.

It is used in the treatment of mild reflux disease and its symptoms (such as heartburn, pain upon swallowing, or regurgitation of gastric contents), in the treatment and prevention of recurrence of esophagitis, and in the prevention of gastric and duodenal ulcers in individuals taking long-term pain medication (NSAIDs).

Form: tablets, enteric-coated

ATC: A02BC02

Manufacturer: Centrafarm Services B.V. Eurogenerics NV/SA Lamp San Prospero S.p.A Jelfa Pharmaceutical Company S.A. Sofarimex Chemical and Pharmaceutical Industry S.A. STADA Arzneimittel AG

The medicine is used in the treatment of gastric and duodenal ulcer disease (including for the eradication of Helicobacter pylori bacteria), in the treatment of reflux esophagitis, and in conditions related to excessive hydrochloric acid secretion in the stomach.

Form: tablets, enteric-coated

ATC: A02BC02

Manufacturer: Centrafarm Services B.V. Eurogenerics NV/SA Lamp San Prospero S.p.A Jelfa Pharmaceutical Company S.A. Sofarimex Chemical and Pharmaceutical Industry S.A. STADA Arzneimittel AG

The medicine is used to treat symptoms such as heartburn, acid regurgitation, or pain upon swallowing associated with gastroesophageal reflux disease. It is also used for the long-term treatment and prevention of recurrence of esophagitis, and in adults, for the prevention of gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs).

Form: tablets, enteric-coated

ATC: A02BC02

Manufacturer: APL Swift Services (Malta) Ltd.

The medicine is used to treat stomach and intestinal diseases related to excessive hydrochloric acid secretion. It is indicated for the treatment of reflux esophagitis, gastric and duodenal ulcer diseases, Helicobacter pylori infection (in combination with antibiotics), and Zollinger-Ellison syndrome.

Form: tablets, enteric-coated

ATC: A02BC02

Manufacturer: APL Swift Services (Malta) Ltd.

The medicine is used for the short-term treatment of symptoms of gastroesophageal reflux disease in adults, such as heartburn or acid regurgitation.

Form: tablets, enteric-coated

ATC: A02BC02

Manufacturer: APL Swift Services (Malta) Ltd.

The drug is used in adults for the treatment of reflux esophagitis, gastric and duodenal ulcer disease, Zollinger-Ellison syndrome, and other disorders related to excessive hydrochloric acid secretion.

Form: powder for preparation of injection solution

ATC: A02BC02

Manufacturer: Lek Pharmaceuticals d.d.

It is used to treat stomach and intestinal diseases caused by hydrochloric acid. It helps relieve reflux symptoms (such as heartburn, acid regurgitation, or pain when swallowing), treats esophagitis, and prevents its recurrence. In adults, it is also used to prevent gastric and duodenal ulcers in individuals who must take continuous anti-inflammatory medication (NSAIDs).

Form: tablets, enteric-coated

ATC: A02BC02

Manufacturer: Lek Pharmaceuticals d.d.

The medicine is used in adults and adolescents (over 12 years of age) for the treatment of reflux esophagitis. In adults, it is also used to treat gastric and duodenal ulcer disease, Helicobacter pylori infection (in combination with antibiotics), Zollinger-Ellison syndrome, and other disorders related to excessive hydrochloric acid secretion.

Form: tablets, enteric-coated

ATC: A02BC02

Manufacturer: Sandoz B.V.

The medicine is used in adults and adolescents (over 12 years of age) for the treatment of reflux esophagitis. In adults, it is also used for the treatment of gastric and duodenal ulcer disease, Helicobacter pylori infection (in combination with antibiotics), and Zollinger-Ellison syndrome and other disorders related to excessive gastric acid secretion.

Form: tablets, enteric-coated

ATC: A02BC02

Manufacturer: Sandoz B.V.

The medicine is used in adults and adolescents (over 12 years of age) for the treatment of reflux esophagitis. In adults, it is also used to treat gastric and duodenal ulcer disease, Helicobacter pylori infection (in combination with antibiotics), and Zollinger-Ellison syndrome and other disorders related to excessive gastric acid secretion.

Form: tablets, enteric-coated

ATC: A02BC02

Manufacturer: Sandoz B.V.

The medicine is used in adults and adolescents over 12 years of age to treat symptoms of gastroesophageal reflux disease (such as heartburn, pain when swallowing, or acid regurgitation) and to prevent recurrences of esophagitis. In adults, it also helps to prevent gastric and duodenal ulcers in individuals who must take continuous anti-inflammatory drugs (NSAIDs).

Form: tablets, enteric-coated

ATC: A02BC02

Manufacturer: Egis Pharmaceuticals PLC Jelfa Pharmaceutical Company S.A.

It is used in the treatment of reflux esophagitis, gastric and duodenal ulcer disease, Helicobacter pylori infection (in combination with antibiotics), and in conditions related to excessive hydrochloric acid secretion, such as Zollinger-Ellison syndrome.

Form: tablets, enteric-coated

ATC: A02BC02

Manufacturer: Egis Pharmaceuticals PLC Jelfa Pharmaceutical Company S.A.

The medicine is used to treat symptoms of stomach and intestinal diseases related to excessive hydrochloric acid secretion. It helps, among other things, with heartburn, acid regurgitation, and pain upon swallowing associated with gastroesophageal reflux disease. In adults, it is also used to prevent gastric and duodenal ulcers in individuals taking anti-inflammatory drugs (NSAIDs).

Form: tablets, enteric-coated

ATC: A02BC02

Manufacturer: Krka, d.d., Novo mesto

The medicine is used in the treatment of stomach and intestinal diseases related to excessive hydrochloric acid secretion. It is indicated for reflux esophagitis, gastric and duodenal ulcer disease, Helicobacter pylori infections (in combination with antibiotics), and Zollinger-Ellison syndrome.

Form: tablets, enteric-coated

ATC: A02BC02

Manufacturer: Krka, d.d., Novo mesto TAD Pharma GmbH

The medicine is used for the short-term treatment of symptoms of gastroesophageal reflux disease in adults, such as heartburn or acid regurgitation.

Form: tablets, enteric-coated

ATC: A02BC02

Manufacturer: Krka, d.d., Novo mesto

The medicine is used for the short-term treatment of symptoms of gastroesophageal reflux disease in adults, such as heartburn or acid regurgitation.

Form: tablets, enteric-coated

ATC: A02BC02

Manufacturer: Krka, d.d., Novo mesto

The medicine is used for the short-term treatment of symptoms of gastroesophageal reflux disease in adults, such as heartburn or acid regurgitation.

Form: tablets, enteric-coated

ATC: A02BC02

Manufacturer: Krka d.d., Novo mesto

The medicine is used for the short-term treatment of symptoms of gastroesophageal reflux disease in adults, such as heartburn or acid regurgitation.

Form: tablets, enteric-coated

ATC: A02BC02

Manufacturer: Krka d.d., Novo mesto

It is used in adults and adolescents over 12 years of age for the treatment of gastroesophageal reflux disease symptoms (such as heartburn, pain during swallowing, or regurgitation of gastric contents) and to prevent gastric and duodenal ulcers in individuals on long-term anti-inflammatory medication (NSAIDs).

Form: tablets, enteric-coated

ATC: A02BC02

Manufacturer: Rottendorf Pharma GmbH

It is used in the treatment of stomach and intestinal diseases related to acid action, such as reflux esophagitis, gastric and duodenal ulcer disease, Zollinger-Ellison syndrome, and Helicobacter pylori infection (in combination with antibiotics).

Form: tablets, enteric-coated

ATC: A02BC02

Manufacturer: Rottendorf Pharma GmbH

The medicine is used in adults and adolescents over 12 years of age to treat symptoms of stomach and intestinal diseases related to hydrochloric acid, such as heartburn, acid regurgitation, or pain when swallowing (reflux disease). It also helps to prevent recurrences of esophagitis and protects against gastric and duodenal ulcers in individuals taking anti-inflammatory drugs (NSAIDs).

Form: tablets, enteric-coated

ATC: A02BC02

Manufacturer: Teva Pharma, S.L.U.

The medicine is used in adults and adolescents over 12 years of age for the treatment of reflux esophagitis. In adults, it is also used for the treatment of gastric and duodenal ulcers, Helicobacter pylori infection (in combination with antibiotics), and Zollinger-Ellison syndrome and other conditions related to excessive gastric acid secretion.

Form: tablets, enteric-coated

ATC: A02BC02

Manufacturer: Teva Pharma, S.L.U.

The medicine is used in stomach and intestinal diseases related to excessive hydrochloric acid production. It helps in the treatment of reflux esophagitis, gastric and duodenal ulcer disease, and Helicobacter pylori infection (in combination with antibiotics). It is also used in Zollinger-Ellison syndrome.

Form: tablets, enteric-coated

ATC: A02BC02

Manufacturer: Actavis Deutschland GmbH & Co. KG

The medicine is used in adults and adolescents over 12 years of age to relieve symptoms of gastroesophageal reflux disease (such as heartburn, pain when swallowing, or acid regurgitation) and to prevent gastric and duodenal ulcers in individuals regularly taking anti-inflammatory drugs (NSAIDs).

Form: tablets, enteric-coated

ATC: A02BC02

Manufacturer: Actavis Deutschland GmbH & Co. KG

The medicine is used to treat symptoms of gastroesophageal reflux disease (such as heartburn, pain on swallowing, or acid regurgitation) and for the long-term treatment and prevention of recurrence of esophagitis. In adults, it also helps to prevent gastric and duodenal ulcers in individuals who must take continuous anti-inflammatory drugs (NSAIDs).

Form: tablets, enteric-coated

ATC: A02BC02

Manufacturer: Biofarm Sp. z o.o. TOWA Pharmaceuticals Europe, S.L.

This medicine is used to treat reflux esophagitis, gastric and duodenal ulcer diseases, Helicobacter pylori infection (in combination with antibiotics), and conditions related to excessive gastric acid secretion, such as Zollinger-Ellison syndrome.

Form: tablets, enteric-coated

ATC: A02BC02

Manufacturer: Biofarm Sp. z o.o. TOWA Pharmaceuticals Europe, S.L.

It is used in adults and adolescents over 12 years of age to treat symptoms of gastroesophageal reflux disease (such as heartburn, pain upon swallowing, or acid regurgitation) and to prevent gastric and duodenal ulcers in individuals who must take continuous anti-inflammatory drugs (NSAIDs).

Form: tablets, enteric-coated

ATC: A02BC02

Manufacturer: Delorbis Pharmaceuticals Ltd. Sofarimex – Chemical and Pharmaceutical Industry, S.A.

The medicine is used in adults and adolescents over 12 years of age for the treatment of reflux esophagitis. In adults, it is also used to treat gastric and duodenal ulcers, Helicobacter pylori infection (in combination with antibiotics), and conditions related to excessive hydrochloric acid secretion, such as Zollinger-Ellison syndrome.

Form: tablets, enteric-coated

ATC: A02BC02

Manufacturer: Idifarma Desarrollo Farmaceutico, S.L.; Netpharmalab Consulting Services; Synoptis Industrial Sp. z o.o.

The medicine is used in the treatment of stomach and intestinal diseases related to excessive hydrochloric acid secretion, such as reflux esophagitis, gastric or duodenal ulcer disease, and Zollinger-Ellison syndrome.

Form: powder for preparation of injection solution

ATC: A02BC02

Manufacturer: Laboratorios Normon, S.A.

The medicinal product is used in adults for the treatment of, among others, reflux esophagitis, gastric and duodenal ulcer disease, Zollinger-Ellison syndrome, and other conditions related to excessive gastric acid secretion.

Form: powder for preparation of injection solution

ATC: A02BC02

Manufacturer: DEMO S.A. Pharmaceutical Industry

The medicine is used in adults for the treatment of stomach and intestinal diseases caused by hydrochloric acid, such as reflux esophagitis, gastric and duodenal ulcers, and Zollinger-Ellison syndrome.

Form: powder for preparation of injection solution

ATC: A02BC02

Manufacturer: Rompharm Company SRL

The medicine is used for the short-term treatment of symptoms of gastroesophageal reflux disease in adults, such as heartburn or acid regurgitation.

Form: tablets, enteric-coated

ATC: A02BC02

Manufacturer: Teva Pharmaceutical Factory Ltd.

The medicine is used for the short-term treatment of symptoms of gastroesophageal reflux disease in adults, such as heartburn or acid regurgitation.

Form: tablets, enteric-coated

ATC: A02BC02

Manufacturer: Teva Pharmaceutical Works Ltd.

The medicine is used in adults for the short-term treatment of symptoms of gastroesophageal reflux disease, such as heartburn or acid regurgitation.

Form: tablets, enteric-coated

ATC: A02BC02

Manufacturer: Teva Pharmaceutical Factory Ltd.

It is used in the treatment of stomach and intestinal diseases related to excess acid. It helps in the treatment of reflux esophagitis, gastric and duodenal ulcers, and Helicobacter pylori infection (in combination with antibiotics). It is also used in Zollinger-Ellison syndrome.

Form: tablets, enteric-coated

ATC: A02BC02

Manufacturer: TOWA Pharmaceuticals Europe, S.L.

The medicine is used in the treatment of stomach and intestinal diseases related to gastric acid, such as reflux esophagitis, gastric and duodenal ulcers, and Helicobacter pylori infection (in combination with antibiotics). It is also used in Zollinger-Ellison syndrome and other conditions involving excessive acid secretion.

Form: tablets, enteric-coated

ATC: A02BC02

Manufacturer: TOWA Pharmaceuticals Europe, S.L.

It is used for the short-term treatment of symptoms of gastroesophageal reflux disease in adults, such as heartburn or acid regurgitation.

Form: tablets, enteric-coated

ATC: A02BC02

Manufacturer: Medicofarma S.A.

The medicine is used for the short-term treatment of symptoms of gastroesophageal reflux disease in adults, such as heartburn or acid regurgitation.

Form: tablets, enteric-coated

ATC: A02BC02

Manufacturer: TOWA Pharmaceuticals Europe, S.L.

It is used in the treatment of stomach and intestinal diseases related to excessive hydrochloric acid secretion, such as reflux esophagitis, gastric or duodenal ulcer disease, Helicobacter pylori infection, and Zollinger-Ellison syndrome.

Form: tablets, enteric-coated

ATC: A02BC02

Manufacturer: Delorbis Pharmaceuticals Ltd. Sofarimex – Chemical and Pharmaceutical Industry, S.A.

The medicinal product is used in adults for the treatment of, among others, reflux esophagitis, gastric and duodenal ulcer disease, Zollinger-Ellison syndrome, and other conditions related to excessive gastric acid secretion.

Form: powder for preparation of injection solution

ATC: A02BC02

Manufacturer: LABORATORIOS NORMON S.A.

The medicine is used for the short-term treatment of symptoms of gastroesophageal reflux disease in adults, such as heartburn (painful burning in the chest reaching up to the throat) and acid regurgitation.

Form: tablets, enteric-coated

ATC: A02BC02

Manufacturer: S.C. Terapia S.A., Sun Pharmaceutical Industries Europe B.V.